| Inhibition of neddylation represses lipopolysaccharide-induced proinflammatory cytokine production in macrophage cells. | |
| | |
MedLine Citation:
|
PMID: 22927439 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Cullin-RING E3 ligases (CRLs) are a class of ubiquitin ligases that control the proteasomal degradation of numerous target proteins, including IκB, and the activity of these CRLs are positively regulated by conjugation of a Nedd8 polypeptide onto Cullin proteins in a process called neddylation. CRL-mediated degradation of IκB, which normally interacts with and retains NF-κB in the cytoplasm, permits nuclear translocation and transactivation of the NF-κB transcription factor. Neddylation occurs through a multistep enzymatic process involving Nedd8 activating enzymes, and recent studies have shown that the pharmacological agent, MLN4924, can potently inhibit Nedd8 activating enzymes, thereby preventing neddylation of Cullin proteins and preventing the degradation of CRL target proteins. In macrophages, regulation of NF-κB signaling functions as a primary pathway by which infectious agents such as lipopolysaccharides (LPSs) cause the up-regulation of proinflammatory cytokines. Here we have analyzed the effects of MLN4924, and compared the effects of MLN4924 with a known anti-inflammatory agent (dexamethasone), on certain proinflammatory cytokines (TNF-α and IL-6) and the NF-κB signaling pathway in LPS-stimulated macrophages. We also used siRNA to block neddylation to assess the role of this molecular process during LPS-induced cytokine responsiveness. Our results demonstrate that blocking neddylation, either pharmacologically or using siRNA, abrogates the increase in certain proinflammatory cytokines secreted from macrophages in response to LPS. In addition, we have shown that MLN4924 and dexamethasone inhibit LPS-induced cytokine up-regulation at the transcriptional level, albeit through different molecular mechanisms. Thus, neddylation represents a novel molecular process in macrophages that can be targeted to prevent and/or treat the LPS-induced up-regulation of proinflammatory cytokines and the disease processes associated with their up-regulation. |
| | |
Authors:
|
Fang-Mei Chang; Sara M Reyna; Jose C Granados; Sung-Jen Wei; Wendy Innis-Whitehouse; Shivani K Maffi; Edward Rodriguez; Thomas J Slaga; John D Short |
Related Documents
:
|
23434459 - Intracellular localization of myeloperoxidase in murine peritoneal b-lymphocytes and ma... 18803229 - The inhibition of free radical generation by preparations of harpagophytum procumbens i... 23457629 - Deficiency in p38β mapk fails to inhibit cytokine production or protect neurons agains... 23386849 - The linkage of innate and adaptive immune response during granulomatous development. 23593279 - Carbon monoxide abrogates ischemic insult to neuronal cells via the soluble guanylate c... 20415419 - 5-hydroxytrytophan inhibits tert-butylhydroperoxide (t-bhp)-induced oxidative damage vi... 10779769 - Thymic dendritic cells express inducible nitric oxide synthase and generate nitric oxid... 19413889 - Minerval induces apoptosis in jurkat and other cancer cells. 22488359 - An additional piece in the puzzle of neutrophil-derived il-1β: the nlrp3 inflammasome. |
Publication Detail:
|
Type: Journal Article Date: 2012-08-27 |
Journal Detail:
|
Title: The Journal of biological chemistry Volume: 287 ISSN: 1083-351X ISO Abbreviation: J. Biol. Chem. Publication Date: 2012 Oct |
Date Detail:
|
Created Date: 2012-10-15 Completed Date: 2012-12-31 Revised Date: 2013-04-16 |
Medline Journal Info:
|
Nlm Unique ID: 2985121R Medline TA: J Biol Chem Country: United States |
Other Details:
|
Languages: eng Pagination: 35756-67 Citation Subset: IM |
Affiliation:
|
Regional Academic Health Center, Medical Research Division, University of Texas Health Science Center at San Antonio, Edinburg, Texas 78541, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Anti-Inflammatory Agents / pharmacology Cell Line, Tumor Cyclopentanes / pharmacology Dexamethasone / pharmacology Humans Inflammation Mediators / metabolism* Interleukin-6 / biosynthesis* Lipopolysaccharides / pharmacology Macrophages / cytology, metabolism* Mice NF-kappa B / metabolism Protein Processing, Post-Translational / drug effects, physiology* Pyrimidines / pharmacology Transcription, Genetic / drug effects, physiology Tumor Necrosis Factor-alpha / biosynthesis* Ubiquitin-Activating Enzymes Ubiquitins / metabolism* Up-Regulation / drug effects, physiology |
| Chemical | |
Reg. No./Substance:
|
0/((1S,2S,4R)-4-(4-((1S)-2,3-dihydro-1H-inden-1-ylamino)-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-2-hydroxycyclopentyl)methyl sulphamate; 0/Anti-Inflammatory Agents; 0/Cyclopentanes; 0/IL6 protein, human; 0/Inflammation Mediators; 0/Interleukin-6; 0/Lipopolysaccharides; 0/NEDD8 protein, human; 0/NF-kappa B; 0/Nedd8 protein, mouse; 0/Pyrimidines; 0/Tumor Necrosis Factor-alpha; 0/Ubiquitins; 50-02-2/Dexamethasone; EC 6.3.2.19/Ubiquitin-Activating Enzymes |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Kcnh1 voltage-gated potassium channels are essential for early zebrafish development.
Next Document: Neutrophil elastase modulates cytokine expression: contribution to host defense against Pseudomonas ...